Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Molecular Diagnostics World Congress

Lilly Kong's Biography

Lilly Kong, Chief Scientific Officer, PrimeraDx

Lilly Kong joined PrimeraDx in early 2009 as CSO. PrimeraDx is dedicated to the emerging field of molecular diagnostics. Lilly directs scientific and technical affairs to support the development and commercialization of the novel molecular quantitative multiplex multi-modal diagnostic platform. Prior to joining PrimeraDx, Lilly served as the Vice President of Research and Development at Focus Diagnostics, a wholly owned subsidiary of Quest Diagnostics, managing both molecular and immunological diagnostic products and laboratory services. Lilly is a veterinarian, virologist and molecular biologist by training. She received a D.V.M. from National Taiwan University, an M.S. in Veterinary Microbiology from Auburn University, and had her postdoctoral fellowship training in Hematology at the University of Alabama, Birmingham.

Lilly Kong Image

Quantitative, Multimodal, Multiplex Molecular Platform for Companion Diagnostic Development

Wednesday, 26 September 2012 at 12:15

Add to Calendar ▼2012-09-26 12:15:002012-09-26 13:15:00Europe/LondonQuantitative, Multimodal, Multiplex Molecular Platform for Companion Diagnostic DevelopmentMolecular Diagnostics World Congress in San Diego, USASan Diego,

A tailored therapeutic approach and personalized medicine has become the norm rather the future of medicine, and pharmaceutical companies need a platform that can 1) perform multimodal complex assays, 2) perform quantitative assays, and 3) perform multiplex assays. High Multiplex, Multimodal qPCR is the next generation of Molecular Diagnostics. The ICEPlex System fulfills all three specifications for a platform that can be used for Companion Diagnostics.

Add to Calendar ▼2012-09-25 00:00:002012-09-26 00:00:00Europe/LondonMolecular Diagnostics World CongressMolecular Diagnostics World Congress in San Diego, USASan Diego,